2-Fluoroanisole

We are 2-Fluoroanisole CAS:321-28-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   2-Fluoroanisole
CAS.NO: 321-28-8
Synonyms:monofluoroanisole;
2-fluoro-anisole;
2-fluoromethoxybenzene;
ortho-fluoroanisole;
2-methoxyfluorobenzene;
Molecular Formula:C7H7FO
Molecular Weight: 126.12800
 
Physical and Chemical Properties:
Density: 1.124 g/mL at 25 °C(lit.)
Melting point: −39 °C(lit.)
Boiling point: 154-155 °C(lit.)
Flash point:140 °F
Index of Refraction:1.494
 
Specification:
Appearance: Colorless Liquid
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:   used in thePharmaceutical intermediate

2-Fluoroanisole


Related News: According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter.3-ciclopropil-3-oxopropanoato de etilo CAS:24922-02-9 “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”5-Fluoro-2-nitrobenzoic acid “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”Ethyl bromoacetate “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.

Related Products
Product Name
1-(3-chloropropyl)-4-methylpiperazine,dihydrochloride View Details
Hexapeptide-11 View Details
4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate View Details
3,5-Dibenzyloxyacetophenone manufacturer 3-Bromo-2-Nitropyridine manufacturer beta-Hydroxybutyric acid sodium salt manufacturer 3-Methyl-2-(4-Chlorophenyl)Butyryl Chloride manufacturer N-(2-chloropyrimidin-4-yl)-2,3-dimethylindazol-6-amine manufacturer